An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD

Respiratory Medicine

Volumn 92, Issue 8, 1998, Pages 993-999

  Yasuda, N ^a   Gotoh, K ^a   Minatoguchi, S ^a   Asano, K ^a   Nishigaki, K ^a   Nomura, M ^a   Ohno, A ^a   Watanabe, M ^a   Sano, H ^a   Kumada, H ^a   Sawa, T ^b   Fujiwara, H ^a  

^a GIFU UNIVERSITY   (Japan)

^b Gifu Municipal Hospital

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD LEVEL; BRONCHIOLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATION; DISEASE COURSE; DISEASE SEVERITY; EMPHYSEMA; FEMALE; HUMAN; HYPOXEMIA; INFLAMMATION; LUNG ALVEOLUS; MALE; OXYGEN THERAPY; PRIORITY JOURNAL;

EID: 13144283622     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(98)90343-2     Document Type: Article

References (35)

1. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984; 142: 67-77.
2. Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WW, Owen-Schaub LB, Roth JA. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 1994; 54: 2287-2291.
3. Tinnemans MM, Lenders MH, tenVelde GP, Ramaekers FC, Schutte B. Alterations in cytoskeletal and nuclear matrix-associated proteins during apoptosis. Eur J Cell Biol 1995; 68: 35-46.
4. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
5. Tsuyuki S, Bertrand C, Erard F et al. Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J Clin Invest 1995; 96: 2924-2931.
6. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: s77-s120.
7. Spencer H, Shorter RG. Cell turnover in pulmonary tissues. Nature 1962; 194: 880.
8. Bowden DH, Davies E, Wyatt JP. Cytodynamics of pulmonary alveolar cells in the mouse. Arch Pathol Lab Med 1968; 86: 667-670.
9. Nadal JA. Obstructive diseases. In: Murray JF, Nadel JA, eds. Respiratory Medicine. 2nd ed. Philadelphia, PA: Saunders, 1994: 1245-1259.
10. Fujita J, Nelson NL, Daughton DM et al. Evaluation of elastase and antielastase balance in patients with chronic bronchitis and pulmonary emphysema. Am Rev Respir Dis 1990; 142: 57-62.
11. Spencer H. Diseases of the bronchial tree. In Pathology of the Lung. 4th edn. London: Pergamon, 1985: 135-147.
12. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169: 1747-1756.
13. Krammer PH, Behrmann I, Daniel P, Dhein J, Debatin KM. Regulation of apoptosis in the immune system. Curr Opin Immunol 1994; 6: 279-289.
14. Itoh N, Yonehara S, Ishii A et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233-243.
15. Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449-1456.
16. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-1178.
17. Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 1995; 14: 1129-1135.
18. Watanabe-Fukunaga R, Brannan CI, Itoh N et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992; 148: 1274-1279.
19. Trauth BC, Klas C, Peters AMJ et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245: 301-304.
20. Cheng J, Zhou T, Liu C et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263: 1759-1762.
21. Knipping E, Debatin KM, Stricker K, Heilig B, Eder A, Krammer PH. Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. Blood 1995; 85: 1562-1569.
22. Tanaka M, Suda T, Haze K et al. Fas ligand in human serum. Nat Med 1996; 2: 317-322.
23. Wada N, Matsumura M, Ohba Y, Kobayashi N, Takizawa T, Nakanishi Y. Transcription stimulation of the Fas-encoding gene by nuclear factor for interleukin-6 expression upon influenza virus infection. J Biol Chem 1995; 270: 18007-18012.
24. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995; 377: 348-351.
25. Godoy I, Donahoe M, Calhoun WJ, Mancino J. Elevated TNF-α production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med 1996; 153: 633-637.
26. Schols A, Buurman W, Brekel A, Dentener M, Wouters E. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996; 51: 819-824.
27. Seishima M, Takemura M, Saito K et al. Highly sensitive enzyme-linked immunosorbent assay for soluble Fas: elevation of soluble Fas in the elderly. Clin Chem 1996; 42: 1911-1914.
28. Kayagaki N, Kawasaki A, Ebata T et al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995; 182: 1777-1783.
29. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980; 47: 1-9.
30. Hugh-Jones P. A simple standard exercise test and its use for measuring exertion dyspnoea. Br Med J 1952; 12: 65-71
31. Sawada S, Tanigawa N, Kobayashi M, Furui S, Ohta Y. Malignant tracheobronchial obstructive lesions: treatment with gianturco expandable metallic stents. Radiology 1993; 188: 205-208.
32. Sato Y, Asoh T, Honda Y, Fujimatsu Y, Higuchi I, Oizumi K. Morphologic and histochemical evaluation of muscle in patients with chronic pulmonary emphysema manifesting generalized emaciation. Eur Neurol 1997; 37: 116-121.
33. Nakamura M, Chiyotani K, Takishima T. Spirometry, analysis of arterial blood gas, degrees of dyspnea, and results of other pulmonary function tests. In Pulmonary Dysfunction in Pneumoconiosis. 1st edn. Tokyo: Maruzen, 1991: 160-168.
34. Itoh N, Yonehara S, Ishii A et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233-243.
35. 1. Am J Respir Crit Care Med 1997; 155: 852-857.